Argus Research Upgrades Zimmer Biomet Holdings to Buy, Announces $150 Price Target
Portfolio Pulse from Benzinga Newsdesk
Argus Research has upgraded Zimmer Biomet Holdings (NYSE:ZBH) from Hold to Buy, with a new price target of $150.
May 21, 2024 | 11:52 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Argus Research has upgraded Zimmer Biomet Holdings from Hold to Buy, setting a new price target of $150. This upgrade is likely to positively impact the stock price in the short term.
The upgrade from Hold to Buy by a reputable firm like Argus Research, along with a specific price target of $150, is a strong positive signal for investors. This is likely to drive buying interest and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100